课题基金 / 基金详情

Administrative Core

Administrative Core
行政核心
批准号:
8067636
负责人:
Andre Elias Nel
金额:
$6.89万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-24 至 2015-04-30
关键词:
AchievementAir PollutionAlgorithmsAntineoplastic AgentsAreaAwardBayesian AnalysisBiological AssayBiometryBudgetsCaliforniaCellsChemicalsChemistryCollaborationsCommunicationCommunitiesComplexComputer softwareConfidential InformationCongressesConsensusDataData AnalysesDatabasesDevelopmentDevicesDiagnosisDoctor of MedicineDoctor of PhilosophyDrug Delivery SystemsDyesEducationEligibility DeterminationEnsureEnvironmentEnvironmental ImpactEvaluationFellowshipFundingGoalsGroup ProcessesGuidelinesHeadHumanIn VitroInformation TechnologyInjuryInstitutesIntellectual PropertyInterdisciplinary StudyInternationalKnowledgeLeadLeadershipLettersLungLung diseasesMagnetic Resonance ImagingMagnetismMedicineMetalsMethodsModelingMolecularNCI Center for Cancer ResearchNanotechnologyNational Cancer InstituteNational Institute of Environmental Health SciencesOccupational activity of managing financesOrganOxidantsParticipantPathway interactionsPersonsPhysiciansPlayPoliciesPostdoctoral FellowPrincipal InvestigatorProceduresProcessProductionProgress ReportsPropertyProtocols documentationPublic SectorPublicationsReportingResearchResearch ActivityResearch InfrastructureResearch PersonnelResearch Project GrantsResearch TrainingResourcesRobin birdRoleSafetyScientific EvaluationScreening procedureSeriesShapesSilicon DioxideSocietiesSource CodeSpectrum AnalysisStatistical MethodsStatistical ModelsStructureStudy SectionSupervisionTeleconferencesTherapeuticTimeToxic effectToxicologyTravelU-Series Cooperative AgreementsUnited States National Institutes of HealthWorkdata integrationdesigndissemination researchexperiencefluorescence imaginghazardmeetingsmembermetal oxidemodel developmentmultidisciplinarynanonanobiologynanomachinenanomaterialsnanomedicinenanoparticlenanosystemsnanotoxicologyorganizational structureoutreachparticleprofessorprogramsprotocol developmentstatisticssymposiumtechnology developmentweb site

项目摘要

项目成果

Andre Elias Nel的其他基金

相似基金

相关文献

中文摘要
翻译
拟议的纳米生物学和预测毒理学中心(CNPT)的研究将由加州纳米系统研究所(CNSI)内的加州大学洛杉矶分校纳米毒理学计划进行。位于加州大学洛杉矶分校校园的中心,CNSI代表了纳米系统相关的四个目标领域的世界级专业知识。 研究包括能源,环境,健康医学和信息技术。 加州大学洛杉矶分校纳米毒理学计划(http://www.cnsi.ucla.edu/nanotox/)的战略是保持一个强大的组织基础设施,支持和整合我们的研究,技术开发,教育和多样性的努力,内部和外部利益相关者,以及促进无缝沟通 在这些社区中。我们的组织结构允许在多学科研究企业中选择,优先考虑,分配和管理资源。全国防止酷刑委员会的活动将纳入这一结构,以便精简执行与下列方面有关的行政程序: 执行拟议的研究计划。 该项目的组织工作详述如下。每个项目和科学核心都由一名项目负责人领导,他将根据中心的总体目标指导该项目内的活动和研究。每个项目领域的领导人的选择取决于每个项目的科学需求。
英文摘要
The research of the proposed Center for Nanobiology and Predictive Toxicology (CNPT) will be carried out by the UCLA Nanotoxicology Program within the California NanoSystems Institute (CNSI). Located centrally on the UCLA Campus, the CNSI represents worid-class expertise in four targeted areas of nanosystems-related research including Energy, Environment, Health-Medicine, and Information Technology. The UCLA Nanotoxicology Program (http://www.cnsi.ucla.edu/nanotox/) strategy is to maintain a strong organizational infrastructure that supports and integrates our research, technology development, educational and diversity efforts, internal and external stakeholders, as well as facilitating seamless communication amongst these communities. Our organizational structure allows for selection, prioritization, distribution, and management of resources within a multidisciplinary research enterprise. The CNPT activities will be integrated within this structure, allowing for streamlined implementation of the administrative processes related to the execution of the proposed research plans. The organization of the project is detailed below. Each project and the Scientific Core is headed by a project leader who will direct the activities and research within that project in accordance with the overall goals of the Center. Selection of leadership for each project area was determined by the scientific needs of each project.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy
Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy
Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy
Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy
海外基金